SCHEMBL7127622

SCHEMBL7127622

O=C(Nc1ccc(OC(F)(F)F)cc1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 7/20 0.66
KMT2A Q03164 6/20 0.66
MEN1 O00255 5/20 0.66
MAPT P10636 5/20 0.66
SMN1; SMN2 Q16637 3/20 0.66
PPARG P37231 3/20 0.66
CYP3A4 P08684 2/20 0.66
MAPK1 P28482 2/20 0.66
TP53 P04637 2/20 0.66
PKM P14618 2/20 0.66
LMNA P02545 2/20 0.66
CYP1A2 P05177 1/20 0.66
CYP2D6 P10635 1/20 0.66
CYP2C9 P11712 1/20 0.66
TSHR P16473 1/20 0.66
NFKB1 P19838 1/20 0.66
CYP2C19 P33261 1/20 0.66
THPO P40225 1/20 0.66
MTOR P42345 1/20 0.66
PMP22 Q01453 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27924935 0.87 MAPT (0.61) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL7130609 0.85 RORC (0.84) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL11911348 0.84 MAPT (0.76) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL18146911 0.84 SMN1; SMN2 (0.71) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL18147812 0.83 RORC (0.76) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL7121705 0.82 RORC (0.80) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL18147432 0.82 RORC (0.80) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL27578953 0.82 GAA (0.73) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL6097331 0.82 RORC (0.79) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL9899066 0.82 MEN1 (0.55) KMT2AMEN1MAPTSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD RORC 67/4885KMT2A 3291/4885MEN1 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.